venBio
Funding rounds backed by venBio.
- Funding disclosed in full
- $37.5M
- Median round
- $37.5M
- Rounds in calculation
- 1
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Caldera Therapeutics Develops bispecific antibody CLD-423 for inflammatory bowel disease | $37.5MSeries A1 | BiotechUnited States |